Biogen
BIIB
$190.52
Share price
-0.85%
Change (1 day)
-34.80%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Biogen (BIIB) - Net assets
Net assets on the balance sheet as of December 2023 : $14.79 B
According to Biogen's latest financial reports the company has $14.79 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Biogen - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $14.79 B | 10.54% |
| 2022-12-31 | $13.38 B | 22.16% |
| 2021-12-31 | $10.95 B | 2.56% |
| 2020-12-31 | $10.68 B | -19.89% |
| 2019-12-31 | $13.33 B | 2.36% |
| 2018-12-31 | $13.03 B | 3.44% |
| 2017-12-31 | $12.59 B | 3.87% |
| 2016-12-31 | $12.12 B | 29.37% |
| 2015-12-31 | $9.37 B | -13.31% |
| 2014-12-31 | $10.81 B | 25.44% |
| 2013-12-31 | $8.62 B | 23.8% |
| 2012-12-31 | $6.96 B | 8.35% |
| 2011-12-31 | $6.42 B | 17.94% |
| 2010-12-31 | $5.44 B | -12.97% |
| 2009-12-31 | $6.26 B | 7.34% |
| 2008-12-31 | $5.83 B | 5.41% |
| 2007-12-31 | $5.53 B | -22.59% |
| 2006-12-31 | $7.14 B | 3.53% |
| 2005-12-31 | $6.90 B | 1.16% |
| 2004-12-31 | $6.82 B | -3.22% |
| 2003-12-31 | $7.05 B | 535.61% |
| 2002-12-31 | $1.10 B | -17.73% |
| 2001-12-31 | $1.34 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 364.71% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | 503.32% | 🇺🇸 USA |
 AbbVie ABBV | $10.39 B | -29.75% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | -57.89% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 455.45% | 🇫🇷 France |
 Gilead Sciences GILD | $22.74 B | 53.72% | 🇺🇸 USA |
 Illumina ILMN | $5.74 B | -61.18% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $58.95 M | -99.60% | 🇺🇸 USA |
 Qiagen QGEN | $3.80 B | -74.27% | 🇳🇱 Netherlands |
 Bio-Rad Laboratories BIO | $8.74 B | -40.94% | 🇺🇸 USA |